Related Experiment Video

Updated: May 25, 2026

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
09:17

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy

Published on: May 3, 2019

Wilms tumor: recent advances in clinical care and biology

Thomas E Hamilton1, Robert C Shamberger

  • 1Department of Surgery, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA. thomas.hamilton@childrens.harvard.edu

Seminars in Pediatric Surgery
|January 18, 2012
PubMed

Insights

Wilms tumor, a common childhood kidney cancer, has seen treatment advances through clinical trials and research. This has led to risk-based therapies improving patient care.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Clinical Trials

Background:

  • Wilms tumor is the predominant renal malignancy in children.
  • Its treatment evolution exemplifies multimodal cancer therapy.
  • Extensive clinical trial data guides current practices.

Purpose of the Study:

  • To review the biological advancements in understanding Wilms tumor.
  • To outline the impact of this knowledge on clinical treatment strategies.
  • To highlight the success of risk-based therapeutic approaches.

Main Methods:

  • Review of accumulated data from well-controlled clinical trials.
  • Analysis of translational research findings.
  • Synthesis of current knowledge on Wilms tumor biology and treatment.

Main Results:

  • Significant progress in understanding Wilms tumor biology.
  • Development of risk-stratified treatment protocols.
  • Improved outcomes due to evidence-based therapeutic evolution.

Conclusions:

  • Advances in Wilms tumor biology have directly informed clinical practice.
  • Multimodal and risk-based therapies are crucial for effective treatment.
  • Continued research is essential for further improving pediatric cancer care.

More Related Videos

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...